FDA Approves Second Tocilizumab Biosimilar FDA Approves Second Tocilizumab Biosimilar

Tocilizumab-aazg (Tyenne) is approved in both intravenous and subcutaneous formulations.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Rheumatology Source Type: news